4-[3-Difluoromethyl-5-(3-fluoro-4-methoxy-D₃-phenyl)-pyrazol-1-yl]benzenesulfonamide

Deracoxib D3 (CAS 2012598-48-8) is a high-purity reference standard produced and distributed by WITEGA Laboratorien Berlin-Adlershof GmbH. Laboratories use this COX-2 inhibitor reference standard to support veterinary NSAID residue testing and robust quantitative workflows. It enables reliable calibration and traceable measurements in LC-MS/MS and GC-MS. As a deuterium labeled analog, it mirrors the native analyte while aiding selectivity. Choose it to streamline method development and confident confirmatory analysis.

In routine analysis, this material supports:

• LC-MS/MS and GC-MS analytical quantification with low limits of detection.
• Creation of calibration curves and assessment of linearity.
• Method validation, including accuracy, precision, and matrix effects.
• Traceability across batches and instruments.
• Confirmatory analysis that meets regulatory acceptance criteria.

Typical applications include:

• Regulated laboratories performing residue control in animal products.
• Pharmaceutical research on cyclooxygenase-2 inhibitor metabolism.
• Metabolism studies and excretion profiling in relevant matrices.
• Multi residue method development for screening and quantitation.
• Quality control programs that demand reproducible results.

Deracoxib D3 (CAS 2012598-48-8) arrives with detailed documentation to support traceability and audit readiness. You can integrate it into existing workflows without extra optimization. It dissolves readily in common LC-MS solvents. Furthermore, consistent lot-to-lot performance helps maintain stable calibration. With support from WITEGA Laboratorien Berlin-Adlershof GmbH, you receive dependable technical information for successful implementation.

You can download your Safety Data Sheet for NS046

For other languages please contact us: witega@witega.de